Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis

被引:39
|
作者
He, Juanjuan [1 ]
Gu, Yuanting [1 ]
Zhang, Shaojin [2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Breast Surg, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol Surg, 1 Jianshe Dong Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
alpha-Carotene; beta-Carotene; Meta-regression; Overall survival; TREND ESTIMATION; DIETARY FACTORS; PREMORBID DIET; SUPPLEMENT USE; RETINOIC ACID; RISK; GROWTH; WOMEN; PROGNOSIS; ASSOCIATION;
D O I
10.1016/j.clbc.2018.07.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We conducted a systemic review and meta-analysis to summarize the association between dietary or supplement vitamin A and breast cancer survival. The dietary intake of beta-carotene was significantly associated statistically with improved breast cancer overall survival. We found no effects from the intake of other vitamin A derivatives (eg, alpha-carotene, beta-cryptoxanthin, lycopene, retinol, lutein) on breast cancer prognosis. Background: The association between vitamin A intake and breast cancer survival has been inconsistent. We conducted a systemic review and meta-analysis to summarize the results on the association between dietary or supplement vitamin A and its derivatives and breast cancer-specific survival and overall survival (OS). Materials and Methods: A comprehensive search of PubMed and EMBASE was performed from inception to January 31, 2018. The summary hazard ratios and 95% confidence intervals were estimated using a random effects model. Results: Ten studies (8 cohort, 1 clinical trial, and 1 of pooled studies), with 19,450 breast cancer cases, were included in the meta-analysis. The dietary intake of beta-carotene was significantly associated with improved breast cancer OS, with a summary hazard ratio of 0.70 (95% confidence interval, 0.50-0.99; I-2 = 37.5%) for the highest versus lowest intake and 0.93 (95% confidence interval, 0.88-0.99; I-2 = 38.7%) per 1200 mu g/day increment of intake when assessing diet before diagnosis. Meta-regression analysis showed that adjustment for body mass index was a modified factor for the association between the intake of beta-carotene and breast cancer OS (P = .013). However, the intake of other vitamin A derivatives (eg, alpha-carotene, beta-cryptoxanthin, lycopene, retinol, lutein) had no effect on breast cancer prognosis when assessing diet before and after the diagnosis. Conclusion: Our findings suggest limited evidence for the significantly inverse association between the prediagnosis dietary intake of beta-carotene and OS among women with breast cancer. However, the intake of other vitamin A derivatives was not significantly associated with survival. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E1389 / E1400
页数:12
相关论文
共 50 条
  • [41] The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis
    Pangarsa, Eko A.
    Rizky, Daniel
    Tandarto, Kevin
    Setiawan, Budi
    Santosa, Damai
    Hadiyanto, Jessica N.
    Kyana, Salma
    Suharti, Catharina
    [J]. ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2940 - 2948
  • [42] Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies
    Yu, Xinnian
    Zhou, Siying
    Wang, Jinyan
    Zhang, Qian
    Hou, Junchen
    Zhu, Lingping
    He, Yunjie
    Zhao, Jianhua
    Zhong, Shanliang
    [J]. BREAST CANCER, 2017, 24 (05) : 643 - 657
  • [43] Author Correction: Consumption of vegetables and fruits and breast cancer survival: a systematic review and meta-analysis
    Juanjuan He
    Yuanting Gu
    Shaojin Zhang
    [J]. Scientific Reports, 8
  • [44] The Relationship between Time to Surgery (TTS) and Survival in Breast Cancer: A Systematic Review and Meta-Analysis
    Su, Yongcheng
    Zheng, Xiaogang
    Ouyang, Zhong
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2021, 50 (09) : 1773 - 1782
  • [45] Migraine and Risk of Breast Cancer: A Systematic Review and Meta-analysis
    Peng, Cheng
    Wu, Kongyuan
    Chen, Xiwen
    Lang, Hui
    Li, Changling
    He, Li
    Chen, Ning
    [J]. CLINICAL BREAST CANCER, 2023, 23 (03) : E122 - E130
  • [46] Everolimus in advanced breast cancer: A systematic review and meta-analysis
    Raphael, J.
    Lefebvre, C.
    Allan, A.
    Helou, J.
    Boldt, G.
    Vandenberg, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [47] Risk Factors of Breast Cancer: A Systematic Review and Meta-Analysis
    Anothaisintawee, Thunyarat
    Wiratkapun, Cholatip
    Lerdsitthichai, Panuwat
    Kasamesup, Vijj
    Wongwaisayawan, Sansanee
    Srinakarin, Jiraporn
    Hirunpat, Siriporn
    Woodtichartpreecha, Piyanoot
    Boonlikit, Sarawan
    Teerawattananon, Yot
    Thakkinstian, Ammarin
    [J]. ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2013, 25 (05) : 368 - 387
  • [48] Resistin and omentin in breast cancer: A systematic review and meta-analysis
    Zoroddu, Stefano
    Di Lorenzo, Biagio
    Paliogiannis, Panagiotis
    Mangoni, Arduino A.
    Carru, Ciriaco
    Zinellu, Angelo
    [J]. CLINICA CHIMICA ACTA, 2024, 562
  • [49] Hypertension and breast cancer risk: a systematic review and meta-analysis
    Hedong Han
    Wei Guo
    Wentao Shi
    Yamei Yu
    Yunshuo Zhang
    Xiaofei Ye
    Jia He
    [J]. Scientific Reports, 7
  • [50] Breast cancer and organ transplantation: Systematic review and meta-analysis
    Lapointe, M.
    Kerbaul, F.
    Meckert, F.
    Cognard, N.
    Mathelin, C.
    Lodi, M.
    [J]. GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2023, 51 (01): : 60 - 72